Glucocorticoid-dependent transcription in skin requires epidermal expression of the glucocorticoid receptor and is modulated by the mineralocorticoid receptor.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
03 11 2020
Historique:
received: 06 08 2020
accepted: 05 10 2020
entrez: 4 11 2020
pubmed: 5 11 2020
medline: 9 3 2021
Statut: epublish

Résumé

Glucocorticoid (GC) actions are mediated through two closely related ligand-dependent transcription factors, the GC receptor (GR) and the mineralocorticoid receptor (MR). Given the wide and effective use of GCs to combat skin inflammatory diseases, it is important to understand the relative contribution of these receptors to the transcriptional response to topical GCs. We evaluated the gene expression profiles in the skin of mice with epidermal-specific loss of GR (GR

Identifiants

pubmed: 33144612
doi: 10.1038/s41598-020-75853-5
pii: 10.1038/s41598-020-75853-5
pmc: PMC7609727
doi:

Substances chimiques

Glucocorticoids 0
Receptors, Glucocorticoid 0
Receptors, Mineralocorticoid 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

18954

Références

J Invest Dermatol. 2016 Dec;136(12):2417-2426
pubmed: 27464843
J Neuroimmunol. 2005 May;162(1-2):97-102
pubmed: 15833364
Endocrinology. 2019 May 1;160(5):1044-1056
pubmed: 30980716
J Invest Dermatol. 2019 Nov;139(11):2281-2291
pubmed: 31247200
Stress. 2018 Sep;21(5):389-402
pubmed: 29614900
FASEB J. 2018 Oct;32(10):5626-5639
pubmed: 29733691
Genesis. 2004 May;39(1):52-7
pubmed: 15124227
Front Endocrinol (Lausanne). 2018 Apr 20;9:185
pubmed: 29731739
Nat Genet. 1999 Sep;23(1):99-103
pubmed: 10471508
FASEB J. 2002 Nov;16(13):1832-4
pubmed: 12223450
PLoS One. 2015 Oct 30;10(10):e0141909
pubmed: 26517722
Pharmacol Ther. 2002 Oct;96(1):23-43
pubmed: 12441176
Trends Endocrinol Metab. 2018 Jan;29(1):42-54
pubmed: 29162310
Mol Cell Endocrinol. 2015 Sep 5;412:281-9
pubmed: 26001834
Am J Physiol Endocrinol Metab. 2011 Sep;301(3):E484-93
pubmed: 21673307
J Invest Dermatol. 2017 Aug;137(8):1630-1637
pubmed: 28359725
J Biol Chem. 2007 Feb 9;282(6):4021-34
pubmed: 17095510
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Mol Endocrinol. 2010 Nov;24(11):2166-78
pubmed: 20880987
Nat Rev Immunol. 2017 Apr;17(4):233-247
pubmed: 28192415
Genes Immun. 2020 May;21(3):150-168
pubmed: 32203088
Cell Death Dis. 2018 May 22;9(6):588
pubmed: 29789551
J Invest Dermatol. 2013 Feb;133(2):361-70
pubmed: 22951731
Eur J Biochem. 2004 Nov;271(21):4178-88
pubmed: 15511223
J Invest Dermatol. 2006 May;126(5):1177-8
pubmed: 16484985
PLoS One. 2020 Jan 10;15(1):e0227520
pubmed: 31923266
J Endocr Soc. 2019 Jul 24;3(10):1917-1930
pubmed: 31598572
Am J Physiol Endocrinol Metab. 2005 Apr;288(4):E701-6
pubmed: 15572653
Eur J Endocrinol. 2015 Oct;173(4):M133-57
pubmed: 26060052
Proc Natl Acad Sci U S A. 2016 Jul 19;113(29):8236-41
pubmed: 27382178
Nucleic Acids Res. 2009 Jan;37(1):1-13
pubmed: 19033363
J Biol Chem. 2004 Oct 15;279(42):43708-15
pubmed: 15292225
Clin Exp Immunol. 2009 Dec;158(3):272-80
pubmed: 19793335
Genome Biol. 2013 Apr 25;14(4):R36
pubmed: 23618408
Int J Mol Sci. 2018 Jun 29;19(7):
pubmed: 29966221
J Invest Dermatol. 2013 Dec;133(12):2771-2779
pubmed: 23756710
Steroids. 2015 Nov;103:72-88
pubmed: 25988614
J Invest Dermatol. 2017 Jul;137(7):1474-1483
pubmed: 28259685
Proc Natl Acad Sci U S A. 2006 Jan 3;103(1):195-200
pubmed: 16368758
Sci Signal. 2019 Apr 16;12(577):
pubmed: 30992401
J Biol Chem. 2017 Apr 28;292(17):7163-7172
pubmed: 28283576
Nat Rev Endocrinol. 2013 Nov;9(11):670-86
pubmed: 24080732
Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2050-5
pubmed: 9482836
Respir Res. 2017 Apr 18;18(1):61
pubmed: 28420398
Nucleic Acids Res. 2010 Jan;38(Database issue):D792-9
pubmed: 19906719

Auteurs

Lisa M Sevilla (LM)

Instituto de Biomedicina de Valencia-Consejo Superior de Investigaciones Científicas (IBV-CSIC), Jaime Roig 11, 46010, Valencia, Spain.

Judit Bigas (J)

Instituto de Biomedicina de Valencia-Consejo Superior de Investigaciones Científicas (IBV-CSIC), Jaime Roig 11, 46010, Valencia, Spain.

Álvaro Chiner-Oms (Á)

Instituto de Biomedicina de Valencia-Consejo Superior de Investigaciones Científicas (IBV-CSIC), Jaime Roig 11, 46010, Valencia, Spain.

Iñaki Comas (I)

Instituto de Biomedicina de Valencia-Consejo Superior de Investigaciones Científicas (IBV-CSIC), Jaime Roig 11, 46010, Valencia, Spain.

Vicente Sentandreu (V)

Universidad de Valencia, Valencia, Spain.

Paloma Pérez (P)

Instituto de Biomedicina de Valencia-Consejo Superior de Investigaciones Científicas (IBV-CSIC), Jaime Roig 11, 46010, Valencia, Spain. pperez@ibv.csic.es.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH